Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children

Vaccine

Volumn 23, Issue 13, 2005, Pages 1540-1548

  Piedra, Pedro A ^a   Gaglani, Manjusha J ^b   Kozinetz, Claudia A ^a   Herschler, Gayla ^b   Riggs, Mark ^b   Griffith, Melissa ^b   Fewlass, Charles ^b   Watts, Matt ^b   Hessel, Colin ^c   Cordova, Julie ^c   Glezen, W Paul ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c MEDIMMUNE   (United States)

Author keywords

Herd immunity; Influenza; Trivalent live attenuated influenza vaccine

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH PROGRAM; HERD IMMUNITY; HUMAN; INFLUENZA; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TIME SERIES ANALYSIS; VACCINATION;

EID: 13444256111     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.09.025     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR 2002;51(RR03):1-31.
2. L. Simonsen, M.J. Clarke, L.B. Schonberger, N.H. Arden, N.J. Cox, and K. Fukuda Pandemic versus epidemic influenza mortality: a pattern of changing age distribution J Infect Dis 178 1998 53 60
3. C.A. Glaser, S. Gilliam, and W.W. Thompson Medical care capacity for influenza outbreaks, Los Angeles Emerg Infect Dis 8 2002 569 574
4. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, and L.J. Anderson Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 2003 179 186
5. W.P. Glezen Emerging infections: pandemic influenza Epidemiol Rev 18 1996 64 76
6. J.G. Wheeler New modalities for preventing and treating influenza Sem Pediatr Infect Dis 12 2002 235 245
7. R.B. Couch, J.A. Kasel, and W.P. Glezen Influenza: its control in persons and populations J Infect Dis 153 1986 431 440
8. D.M. Perrotta, M. Decker, and W.P. Glezen Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza Am J Epidemiol 122 1985 468 476
9. K.M. Neuzil, B.G. Mellen, P.F. Wright, E.F. Mitchel Jr., and M.R. Griffin The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children N Engl J Med 342 2000 225 231
10. H.S. Izurieta, W.W. Thompson, and P. Kramarz Influenza and the rates of hospitalization for respiratory disease among infants and young children N Engl J Med 342 2000 232 239
11. F.M. Munoz The impact of influenza in children Sem Pediatr Infect Dis 13 2002 72 78
12. S.S. Chiu, Y.L. Lau, K.H. Chan, W.H.S. Wong, and J.S.M. Peiris Influenza-related hospitalization among children in Hong Kong N Engl J Med 347 2002 2097 2103
13. J.A.I. Weigl, W. Puppe, and H.J. Schmitt The incidence of influenza-associated hospitalizations in children in Germany Epidemiol Infect 129 2002 525 533
14. G.F. Badger, J.H. Dingle, A.E. Feller, R.G. Hodges, W.S. Jordan Jr., and C.H. Rammelkamp Jr. A study of illness in a group of Cleveland families. Part V. Introduction and secondary attack rates as indices of exposure to common respiratory diseases in the community J Hyg 58 1953 179 182
15. A.S. Monto, F.M. Davenport, J.A. Napier, and T. Francis Jr. Modification of an outbreak of influenza in Tecumseh Michigan by vaccination of schoolchildren J Infect Dis 122 1970 16 25
16. T.A. Reichert, N. Sugaya, D.S. Fedson, W.P. Glezen, L. Simonsen, and M. Tashiro The Japanese experience with vaccinating schoolchildren against influenza N Engl J Med 433 2001 889 896
17. R.B. Belshe, P. Mendelman, and J. Treanor Efficacy of trivalent live attenuated intranasal influenza vaccine in children N Engl J Med 338 1998 1405 1412
18. R.B. Belshe, W.C. Gruber, and P. Mendelman Efficacy of vaccination with live attenuated, cold-adapted, trivalent intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine J Pediatr 136 2000 168 175
19. P.A. Piedra, L. Yan, and K. Kotloff Safety of the trivalent cold-adapted influenza vaccine (CAIV-T) in pre-school aged children Pediatrics 110 2002 662 672
20. K.L. Nichol, P.M. Mendelman, and K.P. Mallon Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial JAMA 282 1999 137 144
21. Piedra PA, Gaglani M, Herschler G, Safety and effectiveness of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children. In: Osterhaus ADME, Hampson AW, Cox N, editors. Proceedings of the World Congress on Options for the Control of Influenza IV, vol. 1219. Elsevier Science; 2001. p. 939-43.
22. M.J. Gaglani, P.A. Piedra, and G.B. Herschler Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children Arch Pediatr Adolesc Med 158 2004 65 73
23. M.E. Halloran, I.M. Longini, and M.J. Gaglani Estimating efficacy of trivalent, cold-adapted influenza virus vaccine (CAIV-T) against influenza A(H1N1) and B using surveillance cultures Am J Epidemiol 158 2003 305 311
24. A.S. Monto Invited commentary: use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy Am J Epidemiol 158 2003 312 315
25. P.A. Piedra, and W.P. Glezen Influenza in children, epidemiology, immunology, and vaccines Sem Pediatr Infect Dis 2 1991 140 146
26. M. Gaglani, M. Riggs, C. Kamenicky, and W.P. Glezen A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease Pediatr Infect Dis J 20 2001 1155 1156
27. M.E. Halloran, C.J. Struchiner, and I.M. Longini Study designs for evaluating different efficacy and effectiveness aspects of vaccines Am J Epidemiol 146 1997 789 803
28. L.G. Rudenko, A.N. Slepushkin, and A.S. Monto Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia J Infect Dis 168 1993 881 887
29. E.S. Hurwitz, M. Haber, and A. Chang Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts JAMA 284 2000 1677 1682
30. Centers for Disease Control and Prevention. Recommendations of the immunization practices advisory committee (ACIP). Prevention and control of influenza. MMWR 1986;35:317-26, 31.
31. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003;52(No. RR-08):1-36.
32. I.M. Longini, J.S. Koopman, A.S. Monto, and J.P. Fox Estimating household and community transmission parameters for influenza Am J Epidemiol 15 1982 736 751
33. I.M. Longini Jr., M.E. Halloran, and A. Nizam Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-enter vaccine trial: implications for influenza epidemic control Vaccine 18 2000 1902 1909
34. A. Oya, and K. Nerome Experience with mass vaccination of young age groups with inactivated vaccines A.P. Kendal P.A. Patriarcha Options for the Control of Influenza 1986 Alan R. Liss Inc. New York 183 192
35. E.S. Hurwitz, M. Haber, and A. Chang Studies of the. 1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness J Infect Dis 182 2000 1218 1221
36. Centers for Disease Control and Prevention. Update: Influenza activity - United States and worldwide, 2000-01 season, and composition of the 2001-02 influenza vaccine. MMWR 2001;50:466-70.
37. Centers for Disease Control and Prevention. Notice to readers: delayed supply ofinfluenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. MMWR 2000;49(27):619-22.
38. P.A. Piedra Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children Sem Pediatr Infect Dis 13 2002 90 96